Upgrade to SI Premium - Free Trial

ONNVF (ONNVF)

0.39 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program August 19, 2026 6:40 PM - StreetInsider Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API July 10, 2026 6:01 PM - StreetInsider Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010 June 30, 2026 6:00 PM - StreetInsider Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010 June 26, 2026 6:00 PM - StreetInsider NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development June 26, 2026 8:30 AM - Globe NewsWire Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010 June 23, 2026 6:00 PM - StreetInsider Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development June 19, 2026 6:01 PM - StreetInsider Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization June 16, 2026 6:01 PM - StreetInsider Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology June 9, 2026 6:00 PM - StreetInsider Full Article List